Nektar Therapeutics Reports Second Quarter 2023 Financial Results

SAN FRANCISCO, Aug. 8, 2023 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2023. Cash and investments in marketable securities at June 30, 2023, were $409.4 million as compared to $505.0 million at December 31,…

Click here to view original post